{"nct_id":"NCT03734991","title":"Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis (VANISH 303)","status":"COMPLETED","status_verified_date":"2021-08","start_date":"2019-01-04","start_date_type":"ACTUAL","primary_completion_date":"2019-08-21","primary_completion_date_type":"ACTUAL","completion_date":"2019-09-04","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["SCYX"]}